trial

Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial

NCTId NCT01936220
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 200 (estimated)
Sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Primary completion 2007-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
200 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
1997-09
Primary completion
2007-02
Eligibility
ALL · 15 Years · 28 Years

Interventions & indications

Drugs
Continuity of specialized careParent groups combined with Continuity of Specialized careDiscontinuity of care, non specialised care

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Lead Sponsor
ZonMw: The Netherlands Organisation for Health Research and DevelopmentCollaborator

Investigators

1
Don Linszen, Prof.dr.Principal Investigator

Sites

1 total
Amsterdam, Netherlands

Facts & assertions

4 sourced
Enrollment
200
Phase
NA
Primary Completion Date
2007-02
Status
UNKNOWN
relationships
The graph out of here
drug
Continuity of specialized care
drug
Parent groups combined with Continuity of Specialized care
drug
Discontinuity of care, non specialised care
drug
lead_sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
company
collaborator
ZonMw: The Netherlands Organisation for Health Research and Development
company
indication
Schizophrenia
indication
Schizophrenia
indication
Social Adjustment
indication
investigator
Don Linszen, Prof.dr.
person